These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23860029)

  • 1. Filtration of protein aggregates increases the accuracy for diagnosing prion diseases in brain biopsies.
    Wemheuer WM; Wrede A; Gawinecka J; Zerr I; Schulz-Schaeffer WJ
    J Neuropathol Exp Neurol; 2013 Aug; 72(8):758-67. PubMed ID: 23860029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases.
    Schulz-Schaeffer WJ; Tschöke S; Kranefuss N; Dröse W; Hause-Reitner D; Giese A; Groschup MH; Kretzschmar HA
    Am J Pathol; 2000 Jan; 156(1):51-6. PubMed ID: 10623653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of disease-related PrP in Danish patients with different subtypes of prion disease.
    Bergström AL; Heegaard PM; Dyrbye H; Lind P; Laursen H
    Clin Neuropathol; 2009; 28(5):321-32. PubMed ID: 19788047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.
    Snowden JS; Thompson JC; Stopford CL; Richardson AM; Gerhard A; Neary D; Mann DM
    Brain; 2011 Sep; 134(Pt 9):2478-92. PubMed ID: 21840888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting.
    Ritchie DL; Head MW; Ironside JW
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):360-8. PubMed ID: 15305981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
    Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
    Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of prion after decontamination procedures: comparative study of standard Western blot, filter retention and scrapie-cell assay.
    Solassol J; Arlotto M; Lehmann S
    J Hosp Infect; 2004 Jun; 57(2):156-61. PubMed ID: 15183247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease.
    Glatzel M; Abela E; Maissen M; Aguzzi A
    N Engl J Med; 2003 Nov; 349(19):1812-20. PubMed ID: 14602879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic prion protein spreading in the peripheral nervous system of a patient with sporadic Creutzfeldt-Jakob disease.
    Favereaux A; Quadrio I; Vital C; Perret-Liaudet A; Anne O; Laplanche JL; Petry KG; Vital A
    Arch Neurol; 2004 May; 61(5):747-50. PubMed ID: 15148153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid dual staining procedure for the quantitative discrimination of prion amyloid from tissues reveals how interactions between amyloid and lipids in tissue homogenates may hinder the detection of prions.
    Hervé R; Collin R; Pinchin HE; Secker T; Keevil CW
    J Microbiol Methods; 2009 Apr; 77(1):90-7. PubMed ID: 19318058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody.
    Moroncini G; Mangieri M; Morbin M; Mazzoleni G; Ghetti B; Gabrielli A; Williamson RA; Giaccone G; Tagliavini F
    Neurobiol Dis; 2006 Sep; 23(3):717-24. PubMed ID: 16876426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human prion diseases: molecular and clinical aspects.
    Glatzel M; Stoeck K; Seeger H; Lührs T; Aguzzi A
    Arch Neurol; 2005 Apr; 62(4):545-52. PubMed ID: 15824251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future molecular diagnostics for prion diseases.
    Lehto MT; Peery HE; Cashman NR
    Expert Rev Mol Diagn; 2006 Jul; 6(4):597-611. PubMed ID: 16824033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease.
    Schoch G; Seeger H; Bogousslavsky J; Tolnay M; Janzer RC; Aguzzi A; Glatzel M
    PLoS Med; 2006 Feb; 3(2):e14. PubMed ID: 16354106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of glycosylation associated with the T183A mutation in human prion disease.
    Grasbon-Frodl E; Lorenz H; Mann U; Nitsch RM; Windl O; Kretzschmar HA
    Acta Neuropathol; 2004 Dec; 108(6):476-84. PubMed ID: 15558291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple and specific detection of abnormal prion protein by a magnetic bead-based immunoassay coupled with laser-induced fluorescence spectrofluorometry.
    Kim JI; Wang C; Kuizon S; Xu J; Barengolts D; Gray PC; Rubenstein R
    J Neuroimmunol; 2005 Jan; 158(1-2):112-9. PubMed ID: 15589044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
    Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
    Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing prion diseases: needs, challenges and hopes.
    Soto C
    Nat Rev Microbiol; 2004 Oct; 2(10):809-19. PubMed ID: 15378045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.